EULAR Network of Trial centres (ENTRI)

The EULAR Network of Trial centres (ENTRI) is an initiative by the EULAR Research Centre, dedicated to facilitating rheumatic and musculoskeletal diseases (RMDs)-related clinical trial delivery for patient benefit, across all countries represented  within the EULAR membership.                                                  

ENTRI aims to:  

1. Create a network of experienced clinical trials centres with access to large cohorts of patients with RMDs, accessible to all investigators and sponsors from both public and private sectors. 
   
   

2. Build capacity and training in clinical trials and experimental medicine studies in close collaboration with EULAR’s Impact of RMDs Survey, RheumaFacts, Advanced Tissue Analysis (coming soon) and the EULAR School of Rheumatology.
    

3. Provide RMD-related clinical trials toolkits underpinned by best practice. 

See infographic

 
EULAR ENTRI is driven by the  EULAR Clinical Research Sub-Committee, led by the chair, Prof. Andrew P. Cope (Professor of Rheumatology, King’s College London, United Kingdom).

   Kick-off meeting in March 2023